カンザス州における多発性骨髄腫の臨床試験
カンザス州内の拠点で、多発性骨髄腫に関する12件の研究が参加者を募集しています。
カンザス州内の都市
公式研究テキスト（英語）
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
- Research Site, Kansas City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07391657A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
- University of Kansas Cancer Center, Kansas City
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07258511A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
- Kansas University Medical Center, Westwood
被験者募集中第4相
18歳以上 · 全性別 · 2026/09/25更新 · NCT05201781Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma
- University of Kansas Cancer Center, Kansas City
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06465316Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
- The University of Kansas Cancer Center - Westwood, Westwood
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT06297226A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma
- University of Kansas, Westwood
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06980480MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
- American Oncology Partners, P.A. Dba MidAmerica Cancer Care, Kansas City
- Ascentist Doctors' Hospital, Leawood
- American Oncology Partners, P.A. Dba MidAmerica Cancer Care, Merriam
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/24更新 · NCT06152575Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- Mercy Hospital Pittsburg, Pittsburg
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/19更新 · NCT04566328Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
- Research Site, Wichita
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/14更新 · NCT07764978Integrated Cancer Repository for Cancer Research
- Saint Luke's Cancer Instititute - South, Overland Park
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
被験者募集中第3相
全年齢 · 全性別 · 2026/06/10更新 · NCT05561387Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
- University of Kansas Clinical Research Center, Westwood
被験者募集中第1相
18歳以上 · 全性別 · 2026/05/19更新 · NCT06433947ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。